Anxiety Disorders: What You Need to Know

At a Glance

About Anxiety Disorders

Anxiety disorders are the most prevalent category of mental health conditions globally and in South Africa. The term encompasses several distinct diagnoses:

• Generalised Anxiety Disorder (GAD): Persistent, excessive worry about a range of subjects, occurring most days, lasting at least 6 months. Associated with muscle tension, poor sleep, restlessness, and concentration difficulty.
• Panic Disorder: Recurrent unexpected panic attacks (sudden surges of intense fear with physical symptoms — rapid heart rate, sweating, breathlessness, dizziness, chest pain) plus ongoing fear of future attacks.
• Social Anxiety Disorder: Marked fear or anxiety about social situations where one may be scrutinised by others. Avoidance behaviour significantly impairs social and occupational functioning.
• Post-Traumatic Stress Disorder (PTSD): Develops after exposure to a traumatic event. Symptoms: intrusive memories, nightmares, hypervigilance, avoidance, emotional numbing. SA has very high rates of PTSD due to violent crime, interpersonal violence, and other traumatic exposures.
• Obsessive-Compulsive Disorder (OCD): Unwanted intrusive thoughts (obsessions) + repetitive behaviours or mental acts to reduce distress (compulsions).

How Anxiety Is Classified

Treatment Options

First Line — SSRIs

SSRIs are first-line pharmacological treatment for most anxiety disorders. The same medications used for depression are used for anxiety (different disorders, same drug class). Response for anxiety may take slightly longer (6–8 weeks) than for depression.

• Escitalopram 10–20mg — effective for GAD, social anxiety, panic disorder. ~R90/month
• Sertraline 50–200mg — broad spectrum; particularly well-studied for PTSD. ~R100/month
• Paroxetine 20–60mg — effective for panic disorder, social anxiety, OCD. ~R120/month

Important: All SSRIs are available as generic in South Africa and are inexpensive. They are NOT CDL-funded — they come from your scheme's day-to-day (d2d) benefit. Most schemes cover generic SSRIs as routine chronic medication on d2d benefit.

SNRIs and Other Options

• Venlafaxine XR 75–225mg — effective for GAD and social anxiety; first-line SNRI. ~R200/month
• Pregabalin 75–300mg — effective for GAD; anticonvulsant mechanism. ~R450/month. Useful when SSRIs are not tolerated.
• Buspirone 15–30mg — non-sedating, non-addictive anxiolytic; less effective for panic. ~R200/month

Benzodiazepines (Short-Term Only)

Benzodiazepines (lorazepam, clonazepam, diazepam) provide rapid relief of acute anxiety but are NOT appropriate for long-term use due to tolerance and physical dependence. Most guidelines recommend maximum 2–4 weeks continuous use. Can be used as bridge therapy while an SSRI takes effect. Very inexpensive as generic.

Cognitive Behavioural Therapy (CBT)

CBT is the first-line psychological treatment for all anxiety disorders. Evidence base is excellent. Particularly effective for panic disorder, social anxiety, OCD, and PTSD. For OCD, a specific form of CBT — exposure and response prevention (ERP) — is the gold standard.

Private psychologist rate: R1,000–R1,500 per session. For routine anxiety, sessions are funded from the day-to-day benefit — anxiety is not itself a PMB condition. PMB psychotherapy applies only in an acute stress event (901T: up to 12 outpatient contacts in lieu of admission) or acute crisis (910T).

Annual Cost Estimates (Private Sector)

The Coverage Reality: Anxiety Is NOT CDL — and NOT a Standing PMB

Unlike depression (a PMB condition under 902T), routine anxiety disorders — GAD, panic disorder, social anxiety — are neither CDL nor PMB conditions. Day-to-day management is funded from the day-to-day benefit. PMB applies only when anxiety arises as an acute stress disorder after significant trauma (901T) or as an acute crisis (910T):

• PMB covers (acute events only): 901T acute stress — up to 3 days hospital admission OR up to 12 outpatient contacts in lieu of admission; 910T acute crisis — up to 3 days hospital-based care
• PMB does NOT cover: routine outpatient anxiety management, SSRI/SNRI medication, benzodiazepines, GP consultations for anxiety management

Medication for anxiety (SSRIs ~R80–120/month) is funded through your scheme's d2d benefit. It is inexpensive. The main cost driver is psychotherapy at R1,000–R1,500/session.

For complex cases — treatment-resistant GAD, OCD requiring intensive ERP, severe PTSD — psychiatric specialist input adds cost. Psychiatrist visits are not PMB-funded as outpatient consultations (only inpatient is PMB).

Scheme Differences That Matter for Anxiety

The most meaningful scheme differences for anxiety patients:

1. Number of outpatient psychotherapy sessions funded from the day-to-day benefit — some schemes fund 20–30 sessions per year with dedicated programmes
2. d2d SSRI formulary coverage — generic escitalopram/sertraline should be on every scheme's d2d formulary
3. Pregabalin d2d coverage — pregabalin (~R450/month) is more expensive than SSRIs; coverage varies
4. EAP (Employee Assistance Programme) integration — many schemes partner with EAP providers for additional counselling sessions
5. PTSD programme — schemes with trauma-focused mental health programmes are valuable for PTSD patients

SADAG Support

SADAG helpline: 011 234 4837 (daily 08:00–20:00). Crisis line: 0800 456 789 (24 hours).

What the PMB covers, in the regulation’s terms

• For acute stress disorder after recent significant trauma, the PMB is up to 3 days of hospital-based care, or up to 12 outpatient therapy sessions instead of an admission. It is one or the other, never both. (901T. Medical Schemes Act regulations, Annexure A; outpatient alternative from the CMS PMB guideline (v1, 30.09.2020).)
• For major depression and bipolar disorder, the PMB is up to 3 weeks (21 days) a year of hospital-based care, including electroconvulsive therapy (ECT), or up to 15 outpatient therapy sessions instead of an admission. It is one or the other, never both. (902T. Medical Schemes Act regulations, Annexure A; outpatient alternative from the CMS PMB guideline (v1, 30.09.2020).)
• For an acute psychiatric crisis (delusional, mood, anxiety, personality or perception disorders), the PMB is up to 3 days of hospital-based care. (910T. Medical Schemes Act regulations, Annexure A.)

Sources

1. National survey — probable anxiety in SA. PMC9650309, 2022.
2. EAPA-SA: Current State of Mental Health in South Africa, 2024 Update.
3. TherapyRoute: Mental Health Coverage in South Africa.
4. SADAG: PMB and mental health conditions.

Ready to check your scheme's anxiety and mental health benefits? Run your AURA medical aid check